Clinical Response in Plaque Psoriasis Patients Switching from Etanercept to Certolizumab Pegol in a Phase 3, Randomized, Controlled Study. J of Skin [Internet]. 2018 Dec. 17 [cited 2025 Apr. 19];2:S86. Available from: https://skin.dermsquared.com/skin/article/view/483